1 April 2008 in Circulation: Arrhythmia and Electrophysiology
Background—
Several distinct forms of focal ventricular tachycardia (VT) from the left ventricle (LV) have been described. We report a new syndrome of VT arising from the base of the posterior papillary muscle in the LV.
Methods and Results—
Among 290 consecutive patients who underwent ablation for VT or symptomatic premature ventricular complexes (PVCs) based on a focal mechanism, 7 patients were found to have an ablation site at the base of the posterior papillary muscle in the LV. All patients had normal LV systolic function and a normal baseline electrocardiogram. The electrocardiogram during VT or PVCs demonstrated a right bundle-branch block and superior-axis QRS morphology in all patients. VT was not inducible by programmed atrial or ventricular stimulation. In 2 patients with sustained VT, overdrive pacing neither terminated VT nor demonstrated any criterion for transient entrainment. Activation mapping localized the earliest site of activation to the base of the posterior papillary muscle in all patients. When Purkinje potentials were recorded at the site of successful ablation, these potentials preceded local ventricular muscle potentials during sinus rhythm. During VT or PVCs, however, the ventricular muscle potential always preceded the Purkinje potentials. After recurrence of VT or PVCs with standard radiofrequency ablation, irrigated ablation was successful in eliminating the arrhythmia in all patients. Over a mean follow-up period of 9 months, all patients have been free of PVCs and VT.
Conclusion—
We present a distinct syndrome of VT arising from the base of the posterior papillary muscle in the LV by a nonreentrant mechanism. Ablation can be challenging, and irrigated ablation may be necessary for long-term success.
1 June 2008 in Heart Rhythm
1 May 2024 in Circulation: Arrhythmia and Electrophysiology
BACKGROUND: Epicardial radiofrequency catheter ablation (RFCA) of idiopathic ventricular arrhythmias (VAs) originating from the left ventricular summit (LVS) is challenging because of the anatomic barriers. On the other hand, RFCA at the endocardial sites near the earliest epicardial activation site of LVS-VAs (anatomic approach) has proven successful. The evolving trends in the approaches and outcomes of RFCA of LVS-VAs at a single center were evaluated. METHODS: We studied 88 consecutive patients with idiopathic LVS-VAs at our institute from 2009 to 2019. These patients were divided into 3 periods: 2009 to 2012 (early), 2013 to 2015 (middle), and 2016 to 2019 (recent). The data were compared among the 3 periods. RESULTS: The RFCA success rate did not significantly change from the early to middle period but significantly increased from the middle to recent period ( P =0.0315). The transpericardial approach usage significantly decreased over the 3 periods. The anatomic approach usage significantly increased over the 3 periods. The use of the transpericardial approach did not affect the RFCA outcomes over the 3 periods. The success rate of the anatomic RFCA tended to increase from the early to middle period and significantly increased from the middle to recent period ( P =0.0412). The number of endocardial locations where RFCA was successful increased over the 3 periods. CONCLUSIONS: Over the 10-year period, the transpericardial approach became decreasingly performed, whereas the anatomic approach became increasingly performed with a satisfactory improvement in the RFCA outcomes of LVS-VAs. The anatomic RFCA became more successful by identifying more and various endocardial locations as target sites.
22 November 2010 in Pacing and Clinical Electrophysiology
1 January 1999 in EP Europace
Aims Various mode-switching algorithms are available with different tachyarrhythmia detection criteria to be satisfied to initiate mode-switching. This study evaluated three different mode-switching algorithms in patients with paroxysmal atrial fibrillation. Methods and Results Seventeen patients completed the study. Three mode-switching algorithms were downloaded as software into the pacemaker, each for 1 month in a single-blind, randomized sequence. The criteria to initiate mode-switching were: mean atrial rate (‘standard’), ‘4-of-7’ or ‘1-of-1’ atrial intervals to exceed the atrial detection rate. Symptoms for each were measured using the Symptom Checklist–Frequency and Severity index. The median number of mode-switch episodes increased from 20 for ‘standard’ to 39 for ‘4-of-7’ (P=0·029 vs ‘standard’) and 103 for ‘1-of-1’ (P=0·0012 vs ‘standard’) onset criteria. Median duration of episodes decreased from 2·5 min with ‘standard’ to 1·4 min with ‘4-of-7’ and 0·4 min with ‘1-of-1’ onset criteria. Frequency of symptoms was lower using ‘4-of-7’ (18·2±12·0 vs 23±12·0, P=0·08) or ‘1-of-1’ (20·4±12·4 vs 23±12·0, P=0·07) than ‘standard’ onset criteria. Severity of arrhythmia tended to be less with either ‘4-of-7’ (16±10·4 vs 19·1±19·4, P=0·12) or ‘1-of-1’ (17·5±10·3 vs 19·1±9·4, P=0·18) than with ‘standard’ onset criteria. Conclusions The more sensitive onset criteria for detection of atrial tachyarrhythmias were associated with lower frequency and severity of symptoms.